WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the 19th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2007 in New York City. The Company’s President and CEO, Steven Rauscher, will provide an overview of the Company; highlight details on the recent market performance of ANTARA® (fenofibrate) capsules and FACTIVE® (gemifloxacin mesylate) tablets in the U.S.; and discuss the Company’s recently announced results for the first nine months of 2007, in which Oscient recorded $54.7 million in revenues.
